Eagles face NFLPA investigation over Jalen Hurts: What’s next?

The Jalen Hurts’ controversy is not going away anytime soon.

id="inarticle-1">The Eagles allowed Hurts to play with a blood clot in their Week 5 loss to the Jacksonville Jaguars in London. Two weeks later, the Eagles shut Hurts down for the season after blood clots spread to both lungs.

id="inarticle-2">

class="excoVideoPlayer article__paragraph">The NFL defended the Eagles’ medical staff on Tuesday night during the league’s annual fall meeting. Dr. Allen Sills, the NFL’s chief medical officer, claimed the Eagles did nothing wrong. The NFL does not plan to punish the Eagles.

id="inarticle-3">Late on Tuesday night, the National Football League Players Association (NFLPA) responded to the NFL’s claims. The NFLPA announced an investigation.

class="middleParagraph" id="inarticle-4">“The NFLPA is not aware of any NFL investigation into the medical care provided to Jalen Hurts,” the NFLPA said in a statement. “In fact, the league previously informed the union that it did not plan to review the care he received. Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred. Determining the facts is essential to ensuring players receive the highest level of care and protection going forward.”

id="inarticle-5">

class="related-articles-container" id="more-by-author">MORE BY CAYDEN STEELE

Eagles playmaker lands on trade block, could be moved soonOct. 20, 2026, 5:44 p.m.

class="related-article-divider">

class="related-article">NFL won’t punish Eagles over Jalen Hurts situationOct. 20, 2026, 4:02 p.m.

class="related-article-divider">The Athletic reported on Tuesday that the NFL concluded Hurts’ situation “was handled appropriately.”

id="inarticle-6">The NFL and NFLPA appear to be butting heads about the Hurts’ situation.

id="inarticle-7">If the NFLPA finds any wrongdoing from the NFL or the Eagles, there could be big repercussions.

id="inarticle-8">Read the original article on NJ.com. Add NJ.com as a Preferred Source by clicking here.